This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
Category: Forschung
I DONATE. My data for better care: the outpatient partner register study
Donate your data for better care with the support of the Outpatient Partner Registry Study. The Outpatient Partner Registry Study collects treatment data and patient self-assessment data in individual modules. By ‘donating’ your data to the registry study, you are helping to improve research into the care of chronic neurological diseases. The Outpatient Partner Registry…
High satisfaction with edaravone (Radicut) in patients with amyotrophic lateral sclerosis (ALS)
Edaravone is approved in Japan under the name Radicut and in the USA under the trade name Radicava for the treatment of amyotrophic lateral sclerosis (ALS). Despite the lack of approval for edaravone in Europe, the drug is also available in Germany as a single import (in accordance with Section 73 of the German Medicines…
International publication on the results of platform-based supply management of assistive devices for ALS
In January 2018, the international journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration published the results of a care management program for assistive devices in amyotrophic lateral sclerosis (ALS) via the Ambulanzpartner internet platform. The provision of assistive devices is of central importance in ALS. Despite its socio-medical relevance, the provision of assistive devices in ALS…
Ambulanzpartner takes part in BMBF competition: “Digital platforms – assistance systems for people”
The Federal Ministry of Education and Research (BMBF) has launched a competition for research funding for innovative platform ideas. In the funding announcement: “Digital Platforms: Assistance systems for people”, the BMBF has called on small and medium-sized enterprises and cooperating research institutions to submit project outlines. Ambulanzpartner Soziotechnologie APST GmbH (together with two research institutes)…
Online recording and monitoring of the ALS-FRSr scale via ambulance partners
The “ALS Functional Rating Scale“(ALS-FRSr) is an internationally established scale for assessing ALS disease severity, which evaluates 12 motor functions (subscales) that are typically impaired in ALS. Since March 2017, we have been offering people with ALS the opportunity to document their individual ALS-FRSr scale online at regular intervals. By repeatedly answering the scale at…
Outpatient partner at the 90th Congress of the German Neurological Society 2017
At this year’s 90th Congress of the German Society of Neurology (DGN) from September 20 to 23 in Leipzig, we will show how outpatient partners in neurological palliative care can use “digital intelligence” to offer new and better care services for some partners. One of our highlights is the development and establishment of a care…
Research project on care innovations for people with ALS by the Federal Ministry of Education and Research with Ambulanzpartner
Ambulanzpartner receives research funding from the Federal Ministry of Education and Research (BMBF) for a project on technical care support for people with amyotrophic lateral sclerosis (ALS). In the ROBINA project, five companies are researching a new type of adaptive human-technology interaction concept together with ambulance partners. The aim of the project is to transfer…
Publication on cross-professional medication management
Medication management comprises the control and monitoring of the medication process from prescription to administration of the medication. Medication management can be used to identify and rectify application errors, adherence problems or adverse drug events. Cross-professional medication management also includes medical (e.g. diagnoses) and nursing (e.g. care, care level) data. This allows medication to be…
AmbulanzPartner in the trade journal NeuroTransmitter
AmbulanzPartner is featured in the current issue of the specialist journal NeuroTransmitter (1/2016 supplement). NeuroTransmitter sees itself as a discussion forum and leading professional-political medium for neurologists, neurologists and psychiatrists in Germany. As the organ of three professional associations, NeuroTransmitter is a must-read for neurologists and neurologists. Our aim with this article is to provide…